Serum levels of microRNA-371-a-3p as a serum biomarker for early detection of relapses of testicular germ-cell tumours
Recruiting
- Conditions
- testicular germ-cell tumourC62.9Testis, unspecified
- Registration Number
- DRKS00019223
- Lead Sponsor
- niversität Bremen Fakultät für Biologie und Chemie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 250
Inclusion Criteria
testicular germ cell tumour, clinical stage 1, no adjuvant therapy
Exclusion Criteria
clinical stage higher than stage 1
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Early detection of tumour relapse: The goal is to determine the time interval between first elevation of microRNA 371 in serum and radiological detection of the relapse
- Secondary Outcome Measures
Name Time Method A persistent elevation of serum microRNA-371a-3p levels does signify micrometastatic spread